Sheldon L. Koenig - 17 Mar 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Issuer symbol
ESPR
Transactions as of
17 Mar 2023
Net transactions value
-$12,479
Form type
4
Filing time
20 Mar 2023, 16:16:56 UTC
Previous filing
15 Mar 2023
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $12,479 -6,999 -2.3% $1.78 292,816 17 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.